Detalles de la búsqueda
1.
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors.
Acta Oncol
; 62(11): 1440-1450, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801288
2.
Baseline status and dose to the penile bulb predict impotence 1 year after radiotherapy for prostate cancer.
Strahlenther Onkol
; 192(5): 297-304, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27079673
3.
Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.
Cancer Invest
; 32(9): 458-63, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25259607
4.
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT.
Curr Oncol
; 31(2): 839-848, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38392056
5.
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation.
Radiother Oncol
; 192: 110088, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38199284
6.
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer.
Radiother Oncol
; 195: 110230, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38503355
7.
Management of 'in-field' skin toxicity in head and neck cancer patients treated with combined cetuximab and radiotherapy.
Oncology
; 85(5): 257-61, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24192693
8.
Dosimetric characterization and use of GAFCHROMIC EBT3 film for IMRT dose verification.
J Appl Clin Med Phys
; 14(2): 4111, 2013 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23470940
9.
Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.
JAMA Netw Open
; 6(10): e2338039, 2023 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37847502
10.
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer.
Front Oncol
; 12: 937934, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36387203
11.
Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Breast J
; 17(6): 586-93, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21951485
12.
Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and Radiotherapy.
Cancers (Basel)
; 13(13)2021 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34209562
13.
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study.
Radiother Oncol
; 158: 74-82, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33639190
14.
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects.
Front Oncol
; 10: 1207, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32850354
15.
Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
Int J Radiat Oncol Biol Phys
; 70(4): 1130-7, 2008 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17881142
16.
Patient-reported urinary incontinence after radiotherapy for prostate cancer: Quantifying the dose-effect.
Radiother Oncol
; 125(1): 101-106, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28826629
17.
Percentage of positive prostate biopsies independently predicts biochemical outcome following radiation therapy for prostate cancer.
Panminerva Med
; 58(2): 109-14, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26211465
18.
Hypofractionated whole-breast radiotherapy and concomitant boost after breast conservation in elderly patients.
Tumori
; 102(2): 196-202, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26350199
19.
Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier.
Radiat Oncol
; 11: 23, 2016 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26911291
20.
Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy.
Radiother Oncol
; 118(1): 92-8, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26777123